Interestingly, a recent study including data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) showed decreasing levels of both YKL-40 and neurogranin with the progression of symptomatic late onset sporadic AD [72]. This evidence concerns the gene CHI3L1 and Alzheimer disease.